VICTOR: A phase III placebo-controlled trial of rofecoxib in colorectal cancer patients following surgical resection
Prif Awduron: | Kerr, D, Dunn, J, Langman, M, Smith, J, Midgley, R, Iveson, C, McConkey, C |
---|---|
Fformat: | Journal article |
Cyhoeddwyd: |
2008
|
Eitemau Tebyg
-
VICTOR: A PHASE III PLACEBO-CONTROLLED TRIAL OF ROFECOXIB IN COLORECTAL CANCER PATIENTS FOLLOWING SURGICAL RESECTION
gan: Midgley, R, et al.
Cyhoeddwyd: (2008) -
Phase III randomized trial assessing rofecoxib in the adjuvant setting of colorectal cancer: final results of the VICTOR trial.
gan: Midgley, R, et al.
Cyhoeddwyd: (2010) -
Rofecoxib and cardiovascular adverse events in adjuvant treatment of colorectal cancer.
gan: Kerr, D, et al.
Cyhoeddwyd: (2007) -
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial.
gan: Huijbers, A, et al.
Cyhoeddwyd: (2013) -
Rofecoxib Induced Purpura
gan: Dogra Sunil, et al.
Cyhoeddwyd: (2004-01-01)